naltrexone and Cirrhoses, Experimental Liver

naltrexone has been researched along with Cirrhoses, Experimental Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dehpour, AR; Ebrahimkhani, MR; Hoseininik, H; Karoon, A; Kendall, T; Kiani, S; Mani, AR; Mann, DA; Moezi, L; Moore, KP; Oakley, F; Payabvash, S; Shariftabrizi, A; Tavangar, SM	1

Other Studies

1 other study(ies) available for naltrexone and Cirrhoses, Experimental Liver

Article	Year
Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut, 2006, Volume: 55, Issue:11 Topics: Animals; Cell Proliferation; Cells, Cultured; Collagen Type I; Liver; Liver Cirrhosis, Experimental; Male; Matrix Metalloproteinase 2; Naltrexone; Narcotic Antagonists; Nitric Oxide; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Tissue Inhibitor of Metalloproteinase-1	2006

Article

Year

Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats.

Gut, 2006, Volume: 55, Issue:11

Topics: Animals; Cell Proliferation; Cells, Cultured; Collagen Type I; Liver; Liver Cirrhosis, Experimental; Male; Matrix Metalloproteinase 2; Naltrexone; Narcotic Antagonists; Nitric Oxide; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Tissue Inhibitor of Metalloproteinase-1

2006